Evidence map›Paper›PMID 29867121›Full record

ArticleScientific reports2018

Cross-talk among HMGA1 and FoxO1 in control of nuclear insulin signaling.

Eusebio Chiefari, Biagio Arcidiacono, Camillo Palmieri, Domenica Maria Corigliano, Valeria Maria Morittu, Domenico Britti, Michal Armoni, Daniela Patrizia Foti, Antonio Brunetti

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.7field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. FOXO1: a pivotal pioneer factor in oral squamous cell carcinoma.American journal of cancer research · 2021
    Review
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Eusebio ChiefariDepartment of Health Sciences, University of Catanzaro "Magna Græcia", Catanzaro, Italy.
Biagio ArcidiaconoDepartment of Health Sciences, University of Catanzaro "Magna Græcia", Catanzaro, Italy.
Camillo PalmieriDepartment of Clinical and Experimental Medicine, University of Catanzaro "Magna Græcia", Catanzaro, Italy.ORCID 0000-0001-6707-4723
Domenica Maria CoriglianoDepartment of Health Sciences, University of Catanzaro "Magna Græcia", Catanzaro, Italy.
Valeria Maria MorittuDepartment of Health Sciences, University of Catanzaro "Magna Græcia", Catanzaro, Italy.ORCID 0000-0001-6790-5734
Domenico BrittiDepartment of Health Sciences, University of Catanzaro "Magna Græcia", Catanzaro, Italy.
Michal ArmoniInstitute of Immunology and Tissue Typing, Rambam Medical Center, Haifa, Israel.
Daniela Patrizia FotiDepartment of Health Sciences, University of Catanzaro "Magna Græcia", Catanzaro, Italy.
Antonio BrunettiDepartment of Health Sciences, University of Catanzaro "Magna Græcia", Catanzaro, Italy. brunetti@unicz.it.
Magna Graecia University · ITRambam Health Care Campus · IL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

As a mediator of insulin-regulated gene expression, the FoxO1 transcription factor represents a master regulator of liver glucose metabolism. We previously reported that the high-mobility group AT-hook 1 (HMGA1) protein, a molecular switch for the insulin receptor gene, functions also as a downstream target of the insulin receptor signaling pathway, representing a critical nuclear mediator of insulin function. Here, we investigated whether a functional relationship existed between FoxO1 and HMGA1, which might help explain insulin-mediated gene transcription in the liver. To this end, as a model study, we investigated the canonical FoxO1-HMGA1-responsive IGFBP1 gene, whose hepatic expression is regulated by insulin. By using a conventional GST-pull down assay combined with co-immunoprecipitation and Fluorescence Resonance Energy Transfer (FRET) analyses, we provide evidence of a physical interaction between FoxO1 and HMGA1. Further investigation with chromatin immunoprecipitation, confocal microscopy, and Fluorescence Recovery After Photobleaching (FRAP) technology indicated a functional significance of this interaction, in both basal and insulin-stimulated states, providing evidence that, by modulating FoxO1 transactivation, HMGA1 is essential for FoxO1-induced IGFBP1 gene expression, and thereby a critical modulator of insulin-mediated FoxO1 regulation in the liver. Collectively, our findings highlight a novel FoxO1/HMGA1-mediated mechanism by which insulin may regulate gene expression and metabolism.

Indexed as

Signal TransductionAnimalsCell NucleusForkhead Box Protein O1Gene Expression RegulationHEK293 CellsHep G2 CellsHMGA ProteinsHumansInsulinInsulin-Like Growth Factor Binding Protein 1LiverMaleMiceMice, KnockoutModels, BiologicalForkhead Box Protein O1FOXO1 protein, humanFoxo1 protein, mouseHMGA ProteinsIGFBP1 protein, humanInsulinInsulin-Like Growth Factor Binding Protein 1

Identifiers

PMID29867121
PMCPMC5986867
OpenAlexW2807007142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.